on 16 Apr 2024
Last Applicant/ Owned by
Bybrook Rd, Porton Down, Salisbury
Wiltshire
GB
SP40BF
Serial Number
97832368 filed on 10th Mar 2023
Registration Number
7358603 registered on 16th Apr 2024
Correspondent Address
Christel Harlacher
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kal Read More
Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system
N/A
N/A
No 97832368
No Service/Collective Mark
No 2051953-0003
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
16th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
16th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
30th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th Jan 2024 | PUBLISHED FOR OPPOSITION |
10th Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
27th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
26th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
26th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
26th Dec 2023 | ASSIGNED TO LIE |
31st Jul 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |